Skip to content
The Waco

Could this drug be the next Ozempic? Lilly reports dramatic trial results

Could this drug be the next Ozempic? Lilly reports dramatic trial results
Photo: KXXV (ABC 25) News · view original

With millions of Americans now taking GLP-1 medications, Eli Lilly says a new experimental drug could deliver more than double the weight loss seen with current treatments. Eli Lilly on Wednesday released Phase 3 trial results for retatrutide, an investigational drug for obesity and Type 2 diabet...

Sources and story details